A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00711178

Enrollment

150

Registered

2008-07-08

Start date

2008-06-30

Completion date

2009-01-31

Last updated

2010-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Actinic Keratoses

Brief summary

A randomised, multi-center study of daylight mediated photodynamic therapy (PDT) with Metvix in patients with multiple actinic keratosis on the face and/or scalp.

Interventions

PROCEDUREPhotodynamic therapy with methyl aminolevulinate

daylight mediated photodynamic therapy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years and older, 5 AK in face and scalp

Exclusion criteria

* immunosuppression

Design outcomes

Primary

Measure	Time frame
response rate	3 months

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026